
CDMO Samsung expands with sixth plant amid 25% revenue growth
The biotech arm of South Korea’s Samsung Group, Samsung Biologics, has four manufacturing plants in the region. During Samsung Biologics’ Q1 financial call, CEO John Rim confirmed that the firm had launched a fifth plant dedicated to antibody-drug …